• Home
  • Latest
  • Coins2Day 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthCoronavirus

COVID vaccine allergies are raising concerns. Most Americans should still get their shots

By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
December 19, 2020, 6:35 PM ET

You may have read that the unprecedented COVID-19 vaccine rollouts in the U.K. And the U.S. Have hit some early road bumps. In the slightly more than a week since the Food and Drug Administration (FDA) gave Pfizer and BioNTech’s coronavirus vaccine an emergency authorization for certain groups at the highest risk of COVID, such as health workers and nursing home residents, there have already been issues with distribution and disparate, confusing policies on to whom exactly the first doses should go.

None of this is all that unexpected, given the highly complex nature of this project and the gamut of stakeholders who need to work together to make a vaccine campaign successful. But one thing that may be giving Americans pause as the effort rolls out is the wave of initial reports of side effects experienced by some of the first people in the U.K. And the U.S. To receive doses of Pfizer’s COVID vaccine, including health workers.

At least two health care professionals in Alaska developed serious reactions, including one who had to be hospitalized. Two other health care workers in the U.K. Developed similar symptoms, including anaphylactic symptoms, but most of the workers recovered from their symptoms quickly, including one within slightly more than an hour. More of these stories will inevitably trickle in, since the vaccine is so new and the sheer number of people, all with different biological peccadilloes, are expected to eventually take it. (We’ll find out in the coming months exactly when other groups can get a shot, which will likely depend on where you live.)

An allergic reaction certainly sounds like an unpleasant prospect, but if it’s deterring you from getting a vaccine, it shouldn’t. Instead, you should keep an eye on potential side effects and prepare to potentially take a day or two off from work if they prove severe.

Although side effects are possible and can be severe, they tend not to be debilitating in most people without a severe history of allergies or inflammatory problems. There’s plenty of evidence of that, both from Pfizer’s and Moderna’s large-scale clinical trials and from the conclusions of the Centers for Disease Control and Prevention (CDC).

That said, side effects are fairly widespread, per the CDC report. The most common by far is some pain at the site of the first COVID vaccine injection, which is usually done in the arm. In a trial of Pfizer’s vaccine versus a placebo, more than 83% of people aged 18 to 55 reported experiencing this side effect.

But 51.1% of the study participants reported that the injection site pain was mild; another 30% reported it was moderate. Severe and above was limited to 1%. Other side effects such as redness and swelling were far more rare. Other common issues, which lasted a median of about one day, according to the CDC, included fatigue, headache, and muscle pain (although which mild to moderate side effects hit which age groups can vary).

Healthy skepticism is understandable. But health care experts note it’s still more important to get a COVID vaccine than risk getting COVID-19 itself. That latter option is far more precarious.

One expert, Dr. Melanie Swift of the Mayo Clinic, recently told Coins2Day that her own health system has developed a grid of side effects related to COVID vaccines versus those related to active coronavirus infections, in order to keep as much of a depleted workforce in place as possible.

So how do these (generally) mild-to-medium, (usually) brief side effects compare to the symptoms that hit you when you actually contract the disease?

“When the virus does cause symptoms, common ones include fever, body ache, dry cough, fatigue, chills, headache, sore throat, loss of appetite, and loss of smell,” according to a guide from Harvard Medical School. “In some people, COVID-19 causes more severe symptoms like high fever, severe cough, and shortness of breath, which often indicates pneumonia. People with COVID-19 are also experiencing neurological symptoms, gastrointestinal (GI) symptoms, or both. These may occur with or without respiratory symptoms.”

There have been more than 17.5 million coronavirus cases and 315,000 COVID-related deaths in the U.S. To date. That’s more than five times as many deaths in the highest range of the CDC’s estimates for annual flu-related deaths since 2010.

Those numbers make an even stronger case for taking a chance on the vaccine.

About the Author
By Sy Mukherjee
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Most Popular

placeholder alt text
Commentary
Yes, you're getting a bigger tax refund. Your kids won't thank you for the $3 trillion it's adding to the deficit
By Daniel BunnJanuary 26, 2026
2 days ago
placeholder alt text
Success
Despite running $75 billion automaker General Motors, CEO Mary Barra still responds to ‘every single letter’ she gets by hand
By Preston ForeJanuary 26, 2026
2 days ago
placeholder alt text
Economy
An unusual Fed ‘rate check’ triggered a free fall in the U.S. dollar and investors are fleeing into gold
By Jim EdwardsJanuary 26, 2026
2 days ago
placeholder alt text
Personal Finance
Current price of silver as of Monday, January 26, 2026
By Joseph HostetlerJanuary 26, 2026
2 days ago
placeholder alt text
Personal Finance
Current price of silver as of Tuesday, January 27, 2026
By Joseph HostetlerJanuary 27, 2026
18 hours ago
placeholder alt text
Success
'The Bermuda Triangle of Talent': 27-year-old Oxford grad turned down McKinsey and Morgan Stanley to find out why Gen Z’s smartest keep selling out
By Eva RoytburgJanuary 25, 2026
3 days ago

© 2026 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.


Latest in Health

People walk outside of a WeWork office building in London.
Future of WorkOffice Culture
Amazon and JPMorgan led the Coins2Day 500 in returning to the office 5 days a week. Now they’re leading a coworking comeback
By Jacqueline MunisJanuary 27, 2026
11 hours ago
Healthbeauty
5 Best Red Light Therapy Panels of 2026: Personally Tested
By Christina SnyderJanuary 27, 2026
11 hours ago
Graphic reads: Coins2Day Titans and Disruptors of Industry with Albert Bourla, CEO of Pfizer, Hosted by Alyson Shontell (both pictured).
C-SuiteCoins2Day 500: Titans and Disruptors of Industry
Pfizer CEO Albert Bourla stared down the COVID-19 pandemic. Now he has his eyes set on cancer 
By Coins2Day EditorsJanuary 27, 2026
22 hours ago
Palantir CEO Alex Karp during an interview at the 2026 World Economic Forum in Davos, Switzerland.
InnovationImmigration
Palantir/ICE connections draw fire as questions raised about tool tracking Medicaid data to find people to arrest
By Tristan BoveJanuary 26, 2026
1 day ago
MagazineLuxury
The $20,000 longevity weekend for those who recognize that more time is the ultimate luxury
By Jaclyn TropJanuary 25, 2026
3 days ago
Secretary of Health and Human Services Robert F. Kennedy Jr. stands at a podium beside a board that depicts an upside-down food pyramid.
HealthFood and drink
Robert F. Kennedy Jr. is redefining the ‘healthy’ American diet—and food companies are making 5 major changes to keep up
By Jake AngeloJanuary 25, 2026
3 days ago